Association Between a Polymorphism in the IL-12p40 Gene and Cytomegalovirus Reactivation After Kidney Transplantation
Authors:
- Jean-Michel HalimiJHJean-Michel Halimi
- Mathias BüchlerMBMathias Büchler
- Florence Velge-RousselFVFlorence Velge-Roussel
- Alain GoudeauAGAlain Goudeau
- Azmi Al NajjarANAzmi Al Najjar
- Marie-Denise BoulangerMBMarie-Denise Boulanger
- Tarik Sqalli HoussainiTHTarik Sqalli Houssaini
- Jean-Frédéric MarliereJMJean-Frédéric Marliere
- Yvon LebranchuYLYvon Lebranchu
- Christophe BaronCBChristophe Baron
- 27 May 2008
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 85 (10) , 1406-1411
Abstract
Cytomegalovirus (CMV) infection is associated with a significant rate of morbidity after organ transplantation. The genetic factors influencing its occurrence have been little investigated. IL-12 plays a crucial role in anti-infectious immune responses, especially by stimulating IFNγ production. An A-to-C single nucleotide polymorphism (SNP) within the 3′-untranslated region of the IL-12p40 gene has been characterized and was reported to be both functionally and clinically relevant. However, the impact of this single nucleotide polymorphism on events after organ transplantation has never been reported. In this study, we investigated the impact of the 3′-untranslated region polymorphism on the occurrence of CMV infection in 469 kidney recipients transplanted at the University Hospital of Tours between 1995 and 2005. The polymorphism was genotyped using the restriction fragment length polymorphism method and CMV infection was determined by pp65 antigenemia. Multifactorial Cox regression analysis demonstrated that the presence of the C allele was an independent risk factor for CMV infection (OR=1.52, P=0.043), the risk being even higher when study was restricted to patients with positive CMV serological status before the graft and who did not receive any CMV prophylaxis (OR=1.88, P=0.028). This study identified a new genetic risk factor for CMV reactivation after kidney transplantation. The results of our study suggest that C carriers might especially benefit from CMV prophylaxis.Keywords
This publication has 39 references indexed in Scilit:
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesThe American Journal of Human Genetics, 2007
- The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantationTransplant Immunology, 2006
- Interleukin 12p40 is required for dendritic cell migration and T cell priming afterMycobacterium tuberculosisinfectionJournal of Experimental Medicine, 2006
- New IL-12-family members: IL-23 and IL-27, cytokines with divergent functionsNature Reviews Immunology, 2005
- Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infectionJournal of Hepatology, 2004
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1Transplantation, 2000
- Interferon γ Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great VesselsJournal of Experimental Medicine, 1998
- IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine ResponsesImmunity, 1996
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992